Cargando…

Gold Standard for Diagnosis of DPN

Diabetic peripheral neuropathy (DPN) is a common complication of diabetes mellitus. It often causes symmetrical paresthesia, loss of sensation, and hyperalgesia. Without early intervention, it might lead to diabetic foot ulceration, gangrene, and subsequent amputation in people with diabetes. DPN is...

Descripción completa

Detalles Bibliográficos
Autor principal: Yu, Yongchun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8576350/
https://www.ncbi.nlm.nih.gov/pubmed/34764937
http://dx.doi.org/10.3389/fendo.2021.719356
_version_ 1784595858858180608
author Yu, Yongchun
author_facet Yu, Yongchun
author_sort Yu, Yongchun
collection PubMed
description Diabetic peripheral neuropathy (DPN) is a common complication of diabetes mellitus. It often causes symmetrical paresthesia, loss of sensation, and hyperalgesia. Without early intervention, it might lead to diabetic foot ulceration, gangrene, and subsequent amputation in people with diabetes. DPN is an insidious disease and often underdiagnosed. This paper reviews the current national and international prevalence of DPN, screening methods for early DPN, including quantitative sensory measurement, neurological function scoring system, confocal microscopy, and high-frequency ultrasound, and summarizes the related research progress, clinical application, and development prospects of these methods in recent years.
format Online
Article
Text
id pubmed-8576350
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-85763502021-11-10 Gold Standard for Diagnosis of DPN Yu, Yongchun Front Endocrinol (Lausanne) Endocrinology Diabetic peripheral neuropathy (DPN) is a common complication of diabetes mellitus. It often causes symmetrical paresthesia, loss of sensation, and hyperalgesia. Without early intervention, it might lead to diabetic foot ulceration, gangrene, and subsequent amputation in people with diabetes. DPN is an insidious disease and often underdiagnosed. This paper reviews the current national and international prevalence of DPN, screening methods for early DPN, including quantitative sensory measurement, neurological function scoring system, confocal microscopy, and high-frequency ultrasound, and summarizes the related research progress, clinical application, and development prospects of these methods in recent years. Frontiers Media S.A. 2021-10-26 /pmc/articles/PMC8576350/ /pubmed/34764937 http://dx.doi.org/10.3389/fendo.2021.719356 Text en Copyright © 2021 Yu https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Endocrinology
Yu, Yongchun
Gold Standard for Diagnosis of DPN
title Gold Standard for Diagnosis of DPN
title_full Gold Standard for Diagnosis of DPN
title_fullStr Gold Standard for Diagnosis of DPN
title_full_unstemmed Gold Standard for Diagnosis of DPN
title_short Gold Standard for Diagnosis of DPN
title_sort gold standard for diagnosis of dpn
topic Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8576350/
https://www.ncbi.nlm.nih.gov/pubmed/34764937
http://dx.doi.org/10.3389/fendo.2021.719356
work_keys_str_mv AT yuyongchun goldstandardfordiagnosisofdpn